Rituximab for Systemic Sclerosis: Helps Skin, but Not Lungs

Rituximab for Systemic Sclerosis: Helps Skin, but Not Lungs

Publication date: Apr 13, 2019

Among 254 patients with SSc followed for a median of 2 years, the modified Rodnan Skin Score declined from a mean of 22. 1 to 14. 1 for those receiving rituximab compared with a decrease from 21. 1 to 16. 2 for controls (P

Concepts Keywords
Lung Anatomy
Lungs Autoimmune diseases
Rituxan RTT
Rituximab Organ systems
Scleroderma Mucinoses
Systemic Sclerosis Drugs
Genentech
Rituximab
Systemic scleroderma

Semantics

Type Source Name
gene UNIPROT ALG3
gene UNIPROT NR4A2
drug DRUGBANK Rituximab
disease MESH Systemic Sclerosis
disease DOID Systemic Sclerosis

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *